보도 자료
EEG Breakthrough: LVIS Corporation Unveils AI Platform That Streamlines Ambulatory Review Workflow
Palo Alto, CA — June 24, 2025 — LVIS Corporation has announced a major enhancement to its unparalleled NeuroMatch® platform with the release of full ambulatory EEG capability—an advancement that promises to streamline one of the most cumbersome and time-intensive processes in neurology. Ambulatory EEG is a critical tool for diagnosing complex neurological conditions like ... Read more
LVIS Corp Set to Revolutionize Epilepsy Diagnosis and Treatment with Launch of NeuroMatch® Elite
Palo Alto, CA — May 28, 2025 — LVIS Corp, a global leader in neurological technology, proudly announces the upcoming U.S. release of NeuroMatch® Elite, a major breakthrough set to revolutionize the future of epilepsy care. NeuroMatch Elite launches with two groundbreaking capabilities — Seizure Source Localization and Spike Source Localization — making it the ... Read more
LVIS NeuroMatch Secures ISO 13485 Certification, Driving Confidence in AI-Powered Neurological Diagnostics
PALO ALTO – April 17, 2025 – LVIS Corporation, a trailblazer in AI-driven neurological diagnostics, proudly announced today that its NeuroMatch product suite has earned ISO 13485 certification. This globally recognized standard for quality management systems in medical devices validates LVIS’s unwavering commitment to delivering safe, reliable, and high-performing solutions that empower clinicians and improve ... Read more
LVIS at KIMES 2025: Pioneering the Future of Brain Health with NeuroMatch and AI Innovation
The 40th Korea International Medical & Hospital Equipment Show (KIMES 2025), held from March 20th to 23rd at the COEX Exhibition Center in Seoul, was a monumental event in the medical industry. With over 1,450 companies showcasing approximately 37,000 state-of-the-art medical devices and hospital equipment, KIMES 2025 celebrated its 40th anniversary. The event also highlighted ... Read more
LVIS Corporation Launches NeuroMatch Pro: AI-Powered Seizure and Spike Detection for Enhanced EEG Diagnostics
Palo Alto, CA – February 6, 2025 – LVIS Corporation has announced the launch of NeuroMatch Pro, an advanced AI-driven platform that builds on the foundation of NeuroMatch to enhance EEG diagnostics. The platform introduces Seizure Detection and Spike Detection, providing powerful tools for the real-time identification and management of seizures and epilepsy-related spike activity. ... Read more
Innovating Epilepsy Care: Highlights from NeuroMatch’s Impact at AES 2024
Each year, the American Epilepsy Society (AES) Annual Meeting brings together the brightest minds in technology for epilepsy, as well as research and treatment. This year, AES 2024 in Los Angeles proved to be an inspiring hub for innovation, collaboration, and discovery. It was an honor for our team at LVIS Corporation to showcase NeuroMatch ... Read more
LVIS Shines at FIX 2024: Pioneering the Future of Brain Health Technology
The Future Innovation Tech Expo (FIX) 2024, held from October 23 to 26 at the Daegu EXCO in South Korea, captured the world’s attention with its expansive display of transformative technologies. With over 463 companies and 2,071 booths under the theme “Better Tech, Better Future,” this event offered a platform to explore future mobility, robotics, ... Read more
LVIS Corporation Signs MOU with Daegu Health College to Foster Next-Generation NeuroMatch Technicians
Palo Alto, CA – November 22, 2024 – LVIS Corporation, an innovator in neural information analysis technology, has signed a Memorandum of Understanding (MOU) with Daegu Health College in South Korea to establish a collaboration for training skilled technicians in the use of NeuroMatch®, LVIS’s cutting-edge AI-driven brain diagnostic technology. This partnership aims to educate ... Read more
LVIS Corporation Launches NeuroMatch® Access: Cloud-Based Platform Revolutionizing EEG Diagnostics
Palo Alto, CA – October 1, 2024– LVIS Corporation, an innovator in neural information analysis technology, has launched NeuroMatch® Access, a cloud-based SaaS platform designed to revolutionize EEG diagnostics by streamlining review and enhancing physician collaboration. This groundbreaking platform, now available to the U.S. market, helps improve clinical workflows allowing neurologists to quickly review and ... Read more
